Jacqueline Scanlan - May 17, 2021 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Signature
/s/ Thomas V. Powers, attorney-in-fact for Ms. Scanlan
Stock symbol
HAE
Transactions as of
May 17, 2021
Transactions value $
-$5,709
Form type
4
Date filed
5/18/2021, 06:27 PM
Next filing
May 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Sale -$5.71K -102 -2.21% $55.97 4.52K May 17, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2 This number includes unvested RSUs previously reported as well as 245 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 30, 2021.